This trial helps find a potent treatment to combat against the weight loss caused as a result of chemotherapy.
Hightower is heading to test a new potential therapy to help overcome chemotherapy-induced anorexia and weight loss in colorectal cancer patients.
Colorectal cancer is a type of cancer that develops in the colon or rectum, often starting as small growths called polyps. If diagnosed at a later stage, it becomes life-threatening. Chemotherapy is one of the most effective treatments administered to help combat this condition.
However, one of the major side effects of chemotherapy is anorexia and weight loss which causes significant discomfort. To help overcome this situation, Hightower clinical is going to conduct a clinical study to test the efficacy of a potential therapy that serves as an antagonist to the weight loss in chemotherapy.
If you or someone you love is suffering through this double tragedy, this study offers a chance to explore better therapeutic options under medical supervision.
Colorectal Cancer/BMI
Upcoming
Oklahoma
This trial helps find a potent treatment to combat against the weight loss caused as a result of chemotherapy.
Eligibility varies by trial but often depends on factors such as the stage of cancer, previous treatments, overall health, and genetic markers.
Benefits: Participants may access cutting-edge treatments before they are widely available and receive close monitoring from specialists.
Risks: Some treatments may have side effects, be less effective than standard options, or require more frequent visits and tests.